Assertio Therapeutics, Inc. (ASRT) Social Stream
Assertio Holdings Inc (ASRT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Assertio Holdings Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued February 16, 2022
Over the past 46 weeks, ASRT's average upside potential has been 331.66%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ASRT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 26 weeks, ASRT's average broker recommendation rating improved by 1.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ASRT as an investment opportunity.
- In the context of all US stocks, Assertio Holdings Inc's number of analysts covering the stock is greater than practically none of them.
- Assertio Holdings Inc's variance in analysts' estimates is lower than just about 100% of all US stocks.
- ASRT has a greater average analyst price target than 8.28% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Assertio Holdings Inc's upside potential (average analyst target price relative to current price) is greater than 48.26% of them.
Make investment decisions regarding ASRT using the data that counts. Try POWR Ratings for free.